High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients

JJ Díez, P Estrada, MA Bajo… - American journal of …, 2009 - karger.com
Aims: Our aim was to evaluate the prognostic value of 2 measurements of serum
adiponectin levels for all-cause mortality and cardiovascular (CV) mortality in uremic …

Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index. Long-term follow-up data of 4.5 years

C Tsigalou, G Chalikias, K Kantartzi, D Tziakas… - Journal of Renal …, 2013 - Elsevier
OBJECTIVES: We sought to investigate the interaction of adiponectin levels and body mass
index (BMI) for predicting all-cause mortality in a cohort of hemodialysis (HD) patients …

Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease–a follow-up study

W Ignacy, J Chudek, M Adamczak… - Nephron Clinical …, 2005 - karger.com
Aim: Malnutrition and inflammation are involved in the pathogenesis of atherosclerosis and
increased risk of cardiovascular diseases in end-stage renal disease. The aim of this study …

Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients–a Japanese prospective eight-year study

F Takemoto, H Katori, N Sawa, J Hoshino… - Nephron Clinical …, 2009 - karger.com
Abstract Background/Aim: Plasma adiponectin may play a protective role in the
pathogenesis of cardiovascular disease in hemodialysis (HD) patients. We examined the …

Association of adiponectin with body composition and mortality in hemodialysis patients

CM Rhee, DV Nguyen, H Moradi, SM Brunelli… - American Journal of …, 2015 - Elsevier
Background In the general population, circulating adiponectin is associated with a favorable
cardiovascular risk profile (eg, lower triglycerides and body fat) and decreased mortality …

Plasma adiponectin levels and clinical outcomes among haemodialysis patients

M Rao, L Li, H Tighiouart, BL Jaber… - Nephrology Dialysis …, 2008 - academic.oup.com
Background. Adiponectin (ADPN) levels are consistently elevated among patients with
advanced chronic kidney disease, but its relationship with cardiovascular outcomes in this …

Adiponectin and cardiovascular outcomes among hemodialysis patients

E Abdallah, E Waked, M Nabil… - Kidney and Blood …, 2012 - karger.com
Background: Adiponectin (ADPN) levels are consistently elevated among patients with
advanced chronic kidney disease, but its relationship with cardiovascular outcomes in this …

Association of serum adiponectin levels with all-cause mortality in hemodialysis patients

N Ohashi, A Kato, T Misaki, M Sakakima… - Internal …, 2008 - jstage.jst.go.jp
Objective Adiponectin (ADPN) has been shown to protect against cardiovascular disease for
the general population with problematic metabolic syndrome. However, it remains unclear …

Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: Long-term follow-up data of 7 years

Y Zhou, J Zhang, W Zhang, Z Ni - Journal of Research in Medical …, 2016 - journals.lww.com
Background: The relationships between adiponectin and clinical outcomes in hemodialysis
(HD) patients remain highly controversial. Meanwhile, the association between adiponectin …

Total and high molecular weight adiponectin concentrations in plasma of patients with end‐stage renal disease before and after peritoneal dialysis

JAEHO PARK, HYOW GIL, JOH YANG… - …, 2008 - Wiley Online Library
Background: Adiponectin is an antiatherogenic adipocyte‐derived proteins. The level of
plasma adiponectin is inversely correlated to cardiovascular risk in patients with end‐stage …